CSPG4 surface expression (above an arbitrary 5% threshold) was observed in 12/12 (100%) melanoma, 5/9 (56%) glioblastoma, 1/4 (25%) lung and 0/12 (0%) renal cancer cell lines (Figure 5B). Here, CSPG4 is linked to melanoma.